Skip to main content
Navigate back to homepage
Open search bar.
Open main navigation menu

Main navigation

  • Study
    UCL Portico statue
    Study at UCL

    Being a student at UCL is about so much more than just acquiring knowledge. Studying here gives you the opportunity to realise your potential as an individual, and the skills and tools to thrive.

    • Undergraduate courses
    • Graduate courses
    • Short courses
    • Study abroad
    • Centre for Languages & International Education
  • Research
    Tree-of-Life-MehmetDavrandi-UCL-EastmanDentalInstitute-042_2017-18-800x500-withborder (1)
    Research at UCL

    Find out more about what makes UCL research world-leading, how to access UCL expertise, and teams in the Office of the Vice-Provost (Research, Innovation and Global Engagement).

    • Engage with us
    • Explore our Research
    • Initiatives and networks
    • Research news
  • Engage
    UCL Print room
    Engage with UCL

    Discover the many ways you can connect with UCL, and how we work with industry, government and not-for-profit organisations to tackle tough challenges.

    • Alumni
    • Business partnerships and collaboration
    • Global engagement
    • News and Media relations
    • Public Policy
    • Schools and priority groups
    • Visit us
  • About
    UCL welcome quad
    About UCL

    Founded in 1826 in the heart of London, UCL is London's leading multidisciplinary university, with more than 16,000 staff and 50,000 students from 150 different countries.

    • Who we are
    • Faculties
    • Governance
    • President and Provost
    • Strategy
  • Active parent page: Brain Sciences
    • Study
    • Research
    • About the Faculty
    • Institutes and Divisions
    • Active parent page: News and Events
    • Contact

Institute researchers show that inflammation and scarring form a positive feedback loop in trachoma

Breadcrumb trail

  • Brain Sciences
  • News and Events

Faculty menu

  • Current page: Faculty news
  • Events

New research performed by Institute doctoral students sheds light on how scarring trachoma can continue long after the infection that starts it has cleared. Results from two studies funded by Fight for Sight suggest that the body’s defence against infection – the immune system – stays active. The results also point to a potential target for treatment.

Trachoma is the world’s leading infectious cause of blindness. It begins with repeated childhood infection of the lining of the eyelid (the conjunctiva) by Chlamydia trachomatis bacteria. It can continue on into adulthood with long-term (chronic) inflammation and scarring, even when the infection can’t be detected.

Scarring tightens the eyelids and turns the lashes inward (trichiasis), where they scratch the eye’s surface. This is painful and eventually leads to blindness.

Trachoma’s molecular footprint

Dr Maryse Bailly at UCL Institute of Ophthalmology led the study published today in the journal Scientific Reports. The team has shown that connective tissue cells (fibroblasts) grown from patients’ conjunctiva biopsies produce more of a molecule called interleukin 6 (IL-6) compared to fibroblasts from healthy conjunctiva.

“IL-6 is an important mediator of inflammation and a previously suggested risk factor for scarring trachoma,” said Dr Jenny Kechagia, who is first author of the study and did the research for her Fight for Sight PhD studentship.

“Our results show that although IL-6 does not stimulate tissue contraction directly, it activates immune cells (macrophages), which in turn stimulates fibroblast contraction and may drive local inflammation. This positive feedback loop between scarring and inflammation may contribute to chronic scarring and suggests that the conjunctival stroma (connective tissue) itself may play a more central role in scarring trachoma than previously thought.”

Recent Fight for Sight PhD student Dr Tamsyn Derrick is first author of the second study, published in PLOS. It was led by Dr Matthew Burton at the London School of Hygiene and Tropical Medicine.

Target connective tissue growth factor

The team found that compared to healthy controls, eyelid tissue from people with scarring trachoma contains significantly more of the pro-inflammatory signalling molecules IL-1Beta and S100A7 and pro-scarring connective tissue growth factor (CTGF). There was evidence of ongoing inflammation in the stroma of individuals with trichiasis even when this inflammation was not externally visible on the patient’s eyelid. This is consistent with the local inflammatory feedback loop proposed by Dr Kechagia.

“CTGF modulates the interaction between cells and the connective tissue, and over activity of CTGF is known to drive scarring disease in the heart, lung and kidney, said Dr Derrick. “Our data suggest that ongoing inflammation in the conjunctiva is associated with CTGF activation, which in turn drives fibrosis and scarring. As a potential direct mediator of inflammation-induced scarring in the conjunctiva, CTGF could be a suitable target for treatment to halt the progression of scarring trachoma.”

Dr Dolores M Conroy is Director of Research at Fight for Sight. She said: “The World Health Organisation estimates that 231 million people live in the regions where trachoma is widespread. Trachoma control programmes do a good job of treating the active infection with antibiotics, however there are a great many people still at risk of progressing to scarring trachoma given that the condition can persist once the infection has gone. In order to develop a treatment that can prevent the chronic inflammation and scarring that lead to blindness, we need to understand how the two are linked. Results from both these studies take us an important step in the right direction.”

UCL footer

Visit

  • Bloomsbury Theatre and Studio
  • Library, Museums and Collections
  • UCL Maps
  • UCL Shop
  • Contact UCL

Students

  • Accommodation
  • Current Students
  • Moodle
  • Students' Union

Staff

  • Inside UCL
  • Staff Intranet
  • Work at UCL
  • Human Resources

UCL social media menu

  • Link to Soundcloud
  • Link to Flickr
  • Link to TikTok
  • Link to Youtube
  • Link to Instagram
  • Link to Facebook
  • Link to Twitter

University College London, Gower Street, London, WC1E 6BT

Tel: +44 (0) 20 7679 2000

© 2025 UCL

Essential

  • Disclaimer
  • Freedom of Information
  • Accessibility
  • Cookies
  • Privacy
  • Slavery statement
  • Log in